Effect of Motor Nerve Block on Muscle Stiffness of Overactive Muscles

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (Other)
Overall Status
Recruiting
CT.gov ID
NCT05510726
Collaborator
(none)
30
1
12
2.5

Study Details

Study Description

Brief Summary

Objective:
  • to investigate the effect of a supraselective motor nerve block (MNB), by the means of local anesthesics injection, on the different components of muscle stiffness of overactive upper and/or lower limb muscles in patients with brain injury

  • to investigate the relationship between muscle stiffness measured by shearwave elastography (SWE) and by MyotonPro

  • to investigate the correlation between muscle stiffness measured by SWE and clinical outcomes

Methods: each patient will be given selective diagnostic motor nerve block. All patients will be evaluated 1 hour before and 1 hour after the MNB.

Outcomes: muscle stiffness measured by sonoelastography and MyotonPro; clinical evaluation (passive range of motion, modified ashworth scale, tardieu scale, fuglmeyer) Hypothesis: MNB will decrease muscle stiffness measured by SWE. The results of SWE will be correlated with the results of MyotonPro and with clinical outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: motor nerve block

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Quantitative Assessment of Muscle Stiffness With Shear Wave Elastography After Motor Nerve Block in Patients With Brain Injury.
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Outcome Measures

Primary Outcome Measures

  1. change of muscle stiffness measured with shearwave elastography (SWE) [same day: 1hour before and 1hour after BMN]

    expressed in m/s. A smaller shearwave velocity indicates a better outcome

Secondary Outcome Measures

  1. change of muscle stiffness assessment with MyotonPro [same day: 1hour before and 1hour after BMN]

    a smaller muscle stiffness indicates a better outcome

Other Outcome Measures

  1. change of passive range of motion [same day: 1hour before and 1hour after BMN]

    expressed in angles °. The greater the angle, the better the outcome

  2. change of modified ashworth scale [same day: 1hour before and 1hour after BMN]

    minimum score:0; maximum score: 4. A higher score indicates a greater spasticity thus a worse outcome

  3. change of Tardieu scale [same day: 1hour before and 1hour after BMN]

    minimum score:0; maximum score: 4. A higher score indicates a greater spasticity thus a wourse outcome

  4. change of Fugl-meyer score [same day: 1hour before and 1hour after BMN]

    maximum score of 100. The highest the score, the better the motor function

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age > 18 years

  • hemiparesia/-plegia following brain injury (TBI, stroke,...)

  • 3 months after brain injury

  • muscle overactivity in upper and/or lower limb requiring injection of botulinum toxin thus a diagnostic MNB before (best clinical practice)

Exclusion Criteria:
  • other neurological or orthopaedic conditions involving the affected limb

  • aphasia or major cognitive impairment limiting functional assessment

  • botulinum toxin injection in the last 3 months

  • previous treatment of muscle overactivity with surgical procedures.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cliniques Universitaires Saint-Luc Brussels Belgium 1200

Sponsors and Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Investigators

  • Principal Investigator: Gaëtan Stoquart, MD, PhD, Cliniques universitaires Saint-Luc

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT05510726
Other Study ID Numbers:
  • 2018/18MAI/217
First Posted:
Aug 22, 2022
Last Update Posted:
Aug 22, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2022